Gensight Biologics SA (SIGHT) — Financial Flexibility Index
Gensight Biologics SA (SIGHT) has a Financial Flexibility Index of 0.00x as of December 2025. Free cash flow of €0.00 (operating CF €-6.49 Million minus capex €6.49 Million) represents 0% of total liabilities (€33.20 Million). Check SIGHT capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Gensight Biologics SA Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for Gensight Biologics SA across 13 annual periods. See SIGHT current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Gensight Biologics SA (2013–2025)
Year-by-year free cash flow to debt coverage for Gensight Biologics SA. For the full company profile including market capitalisation, see SIGHT company net worth.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.28x | €-9.37 Million | €-9.38 Million | €33.20 Million | ▲ +17.8% |
| 2024 | -0.34x | €-12.94 Million | €-12.94 Million | €37.68 Million | ▲ +44.5% |
| 2023 | -0.62x | €-24.65 Million | €-24.66 Million | €39.83 Million | ▲ +23.9% |
| 2022 | -0.81x | €-33.50 Million | €-33.75 Million | €41.22 Million | ▼ -93.2% |
| 2021 | -0.42x | €-17.11 Million | €-17.14 Million | €40.66 Million | ▲ +0.1% |
| 2020 | -0.42x | €-15.04 Million | €-15.04 Million | €35.69 Million | ▲ +68.8% |
| 2019 | -1.35x | €-28.04 Million | €-28.11 Million | €20.74 Million | ▲ +35.8% |
| 2018 | -2.10x | €-27.59 Million | €-28.38 Million | €13.11 Million | ▲ +18.1% |
| 2017 | -2.57x | €-18.55 Million | €-18.78 Million | €7.22 Million | ▲ +22.2% |
| 2016 | -3.30x | €-19.45 Million | €-19.64 Million | €5.89 Million | ▼ -102.5% |
| 2015 | -1.63x | €-11.39 Million | €-12.09 Million | €6.98 Million | ▼ -29.7% |
| 2014 | -1.26x | €-5.33 Million | €-5.52 Million | €4.24 Million | ▼ -49.1% |
| 2013 | -0.84x | €-1.61 Million | €-1.95 Million | €1.91 Million | — |